Lords Weigh Safeguards, ECHR Risks in Assisted Dying Bill

High-Level Summary

The House of Lords continued Committee stage of the Terminally Ill Adults (End of Life) Bill (11th day), completing further debate on Clause 4 before opening Clause 5. Ministers restated government neutrality on policy while highlighting legal (European Convention on Human Rights) and operational risks in several amendments. The Bill’s sponsor, Lord Falconer of Thoroton, defended the existing doctor-and-panel model and said he will bring further amendments on regulation of substances. A large set of amendments on who may raise assisted dying with patients—particularly protections for people with learning disabilities and for children—was examined; the sponsor outlined an independent‑advocate requirement for vulnerable groups. No divisions occurred; principal amendments were withdrawn and the House adjourned at 5.35 pm.

Detailed Summary

Arrangement of Business – Announcement

Lord Kennedy of Southwark outlined the day’s conduct: “Again, I will look to adjourn our proceedings at around 6 pm.” He confirmed participation rules for the resumed group, asking Whips “to monitor this and ensure that only those on the list participate.” He also reminded Members: “conversations during the debate are not welcome.”

Clause 4: Voluntary Assisted Dying Commissioner — resumed debate on Amendment 142 (group)

For the Government, Baroness Levitt said Ministers are policy‑neutral but would flag material legal and workability issues: “The Government’s position remains that it is for Parliament to consider the policy.” She cited Article 6 risks (e.g., time limits and review bars) and Article 8 risks (e.g., publication of applicants’ names and mandatory notifications): Amendment 498 “has the potential to breach Article 6”; Amendment 462B “would introduce a blanket requirement for the publication of a person’s name”. She also warned that requiring the Judicial Appointments Commission to make appointments would conflict with its statutory framework.

Lord Falconer of Thoroton argued the Bill’s current appointments and panel structure are sufficient: “The Bill currently places the obligation of the appointment of panel members on the voluntary assisted dying commissioner … I believe that that is adequate.” He rejected giving panels court‑like powers: “That would not be appropriate. This is not a court; it is a panel.” On hearings, he supported privacy at the patient’s request while otherwise remaining public: “if the patient wants it to be in private, it should be in private.” Lord Murray of Blidworth withdrew Amendment 142, maintaining that panel decisions concern life and death: “it is plainly a decision—a question—of life and death that the panel is making … I beg to withdraw my amendment.”

Amendment 143 and related proposals: multidisciplinary panels, a separate service, and regulation of substances

Baroness Finlay of Llandaff proposed replacing the doctor‑led eligibility checks with a multidisciplinary panel and establishing a separately licensed assisted dying service. Citing external evidence, she said: “Any assisted dying service should be seen as a standalone … service … and … not be deemed core GP work” and must be “separately and adequately resourced.” Her model would include “a lawyer, a social worker or psychologist, a specialist in end-of-life care” and a disease specialist, with licensing, record‑keeping and data‑reporting duties, and tighter control of substances (e.g., MHRA/Misuse of Drugs Act compliance).

Views diverged on integration with palliative care. Baroness Murphy said that in other countries “assisted dying usually happens as part of a palliative care service”, while Lord Deben argued for a clear separation, stating palliative care is “utterly separate from the idea that they can instead decide to kill themselves.” Baroness Hollins urged formal MHRA involvement, noting limited evidence on regimens and outcomes, including “very common complications in 10% of cases” and a “median time to death [of] 53 minutes” in Oregon data. For the Government, Baroness Blake said this package “would lead to major technical, legal or operational workability concerns”, and raised difficulties with mandating clinical trials and device approvals under current frameworks. The sponsor considered the alternative scheme “overengineered” and preferred the Bill’s two‑doctor‑plus‑panel model, but acknowledged the need to refine regulation of substances: “I accept in principle that I have to come back with further amendments … to Clauses 27 and 37.” Baroness Finlay withdrew Amendment 143, and Clause 4 was agreed.

Clause 5: Preliminary discussions with medical practitioners — who may raise assisted dying; safeguards for vulnerable groups

Baroness Grey‑Thompson’s Amendment 149 sought to bar doctors from raising assisted dying within 48 hours of diagnosis and before a multi‑agency needs assessment, noting evidence that “the first week after diagnosis has the highest risk for suicide.” Multiple amendments would prohibit clinicians from initiating such discussions to avoid undue influence, including for people with learning disabilities. Lord Shinkwin cited polling showing “84% of people believe that assisted dying should be initiated only by the patient”, and Baroness Campbell of Surbiton cautioned that a doctor’s suggestion at a fragile point “risks being heard not as an option but as a judgment.” By contrast, Baroness Blackstone argued a ban would be “entirely wrong” and referenced BMA advice that prohibiting doctors from ever initiating discussion would be detrimental to patient care.

Responding, the Government warned that some prohibitions could be hard to enforce and “could give rise to legal challenge on ECHR grounds,” including under Articles 8, 10 and 14. Lord Falconer grouped responses for three cohorts. For adults generally, he stressed Clause 5 requires any preliminary discussion to be contextualised: “such a preliminary discussion may not be conducted in isolation” from illness, treatment and palliative options, and “no doctor can comply with this provision without knowing the full details of the patient’s position”. For vulnerable adults, he outlined a forthcoming amendment to require an independent advocate for defined groups during “relevant” activities, including preliminary discussions: officials “must not carry out that relevant activity unless the person … has an ‘independent advocate’.” For children, he reaffirmed that clinicians cannot raise the subject: “No registered medical practitioner or other health professional shall raise the subject … with a person under the age of 18.” He also noted Victoria’s removal of its prohibition on clinicians initiating discussion after a statutory review, with the change due to take effect in 2027. Amendment 149 was withdrawn and related amendments were not moved. The House adjourned at 5.35 pm.